Share

Clinical Studies (1)

  • Maglione : Study aims to identify risk factors for severe bronchiolitis in two consecutive respiratory syncytial virus (RSV) seasons (before and after the introduction of nirsevimab) in Southern Italy

Study Data

  • General population
  • Infants (<1 year)
  • Hospital
  • SARS-CoV-2
  • Respiratory syncytial virus
  • Influenza virus
  • Acute COVID-19
  • Respiratory syncytial virus infection
  • Influenza
  • Pharmacological intervention
  • Monoclonal antibodies
  • Nirsevimab

Other information

If you would like to contact the site, please email: ccb@ateneo.univr.it

The data is updated up to